Promising outlook for new pancreatic cancer treatment pioneered at the JGH
Clinical trials and further research are under way into the use of endoscopic techniques to embed radioactive materials in tumours.
Cancer during pregnancy: Fear, anxiety and, in many cases, a joyous outcome
Despite the difficulties faced by mothers-to-be with cancer, a multidisciplinary treatment team at the JGH gives them good reason to hope for the best.
90th anniversary flashback: Launch of the Herzl Dispensary, a JGH forerunner
Launched in 1912, the Herzl Dispensary provided care to Montreal’s growing Jewish population and served as a forerunner of the JGH.
Improved surgical procedures offer new hope in treating prostate cancer
Minimally invasive procedures—one new, one upgraded—are viable alternatives to radical surgery and radiation therapy.
From the archives: Michael Douglas praises JGH expertise in diagnosing his throat cancer
In May 2010, Michael Douglas offered public thanks to Dr. Saul Frenkiel, former Chief of the JGH Division of Otolaryngology, for correctly diagnosing the actor’s throat cancer after other physicians had missed it.
Applying artificial intelligence to cancer diagnosis
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.
Pioneering effort to apply novel biotechnology to cancer research
The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.
Brain tumours removed
through eyebrow incision
The eyebrow—and a small section of the bone behind it—has become the latest point of entry in reaching and removing brain tumours.